Compounds > farnesol

farnesol and oleylamine

farnesol has been researched along with oleylamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, KK; Chambers, AF; Guthrie, N; Kothapalli, R; Lui, EM1
Habiro, A; Izawa, T; Kohgo, Y; Mizukami, Y; Obara, T; Osanai, M; Tanno, S; Ura, H; Yanagawa, N1
Mizukami, Y1

Other Studies

3 other study(ies) available for farnesol and oleylamine

ArticleYear
Effects of long-chain fatty amines on the growth of ras-transformed NIH 3T3 cells.
    Biochemical pharmacology, 1994, May-18, Volume: 47, Issue:10

    Topics: 3T3 Cells; Amines; Animals; Calcium; Cell Division; Cell Line, Transformed; Farnesol; Fatty Acids; Genes, ras; Mice; Protein Kinase C

1994
Requirement of c-jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells.
    Biochemical and biophysical research communications, 2001, Oct-19, Volume: 288, Issue:1

    Topics: Alkyl and Aryl Transferases; Amines; Antineoplastic Agents; Apoptosis; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Genes, ras; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Mutation; Pancreatic Neoplasms; Tumor Cells, Cultured

2001
[Oleylamine (long-chain fatty amine)-induced cell death through MAP kinase pathways in human pancreatic cancer cells].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2002, Volume: 77, Issue:1

    Topics: Amines; Apoptosis; Enzyme Inhibitors; Farnesol; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Tumor Cells, Cultured

2002